Robert Gagnon
Director/Board Member presso PURPLE BIOTECH LTD.
Patrimonio netto: 341 292 $ in data 29/02/2024
Profilo
Robert E.
Gagnon holds the position of Chief Financial Officer at Remix Therapeutics, Inc. and Secretary, Treasurer & Director for KD Scientific, Inc. He is also on the board of Verastem, Inc., Purple Biotech Ltd., Bone Biologics Corp.
and Verastem Oncology.
He previously held the position of Chief Financial Officer, Treasurer & Executive VP at Clean Harbors, Inc., Chief Financial Officer at Harvard Bioscience, Inc., Chief Financial & Business Officer at Verastem, Inc., Manager-Research & Development at Zimmer Biomet, Inc. and CAO, VP-Business Planning & Controller at Biogen, Inc.
Mr. Gagnon received an MBA from MIT Sloan School of Management and an undergraduate degree from Bentley University.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
VERASTEM, INC.
0.11% | 19/03/2024 | 27 391 ( 0.11% ) | 341 292 $ | 29/02/2024 |
BONE BIOLOGICS CORP.
-.--% | 08/01/2024 | 0 ( -.--% ) | - $ | 29/02/2024 |
Posizioni attive di Robert Gagnon
Società | Posizione | Inizio |
---|---|---|
PURPLE BIOTECH LTD. | Director/Board Member | 03/03/2021 |
VERASTEM, INC. | Director/Board Member | 13/12/2022 |
BONE BIOLOGICS CORPORATION | Director/Board Member | 08/01/2024 |
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | Director/Board Member | - |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Director of Finance/CFO | - |
Precedenti posizioni note di Robert Gagnon
Società | Posizione | Fine |
---|---|---|
VERASTEM, INC. | Director of Finance/CFO | 31/10/2022 |
HARVARD BIOSCIENCE, INC. | Director of Finance/CFO | 31/08/2018 |
Zimmer Biomet, Inc. | Chief Tech/Sci/R&D Officer | 01/01/2017 |
CLEAN HARBORS, INC. | Director of Finance/CFO | 04/02/2013 |
░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formazione di Robert Gagnon
Bentley University | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 5 |
---|---|
CLEAN HARBORS, INC. | Industrial Services |
BIOGEN INC. | Health Technology |
HARVARD BIOSCIENCE, INC. | Health Technology |
VERASTEM, INC. | Health Technology |
PURPLE BIOTECH LTD. | Health Technology |
Aziende private | 4 |
---|---|
KD Scientific, Inc.
KD Scientific, Inc. Medical SpecialtiesHealth Technology KD Scientific, Inc. provides liquid handling products. It offers syringe pumps, evaporators, concentrators, and accessories. The company was founded on May 02, 1991 and is headquartered in Holliston, MA. | Health Technology |
Bone Biologics Corp. | |
Remix Therapeutics, Inc.
Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA. | Health Technology |
Zimmer Biomet, Inc. |